Celldex Therapeutics Commences Common Stock Offering; Terms Undisclosed
Celldex Therapeutics, Inc. ("Celldex" or the "Company") (NASDAQ:CLDX) today announced that it has commenced an underwritten public offering for the sale of shares of its common stock. In addition, Celldex expects to
04/01/2026